Electrocore Inc stock is traded at $4.84, with a volume of 159,220. It is down -7.81% in the last 24 hours and down -38.34% over the past month. electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Previous Close:
$5.25
Open:
$5.33
24h Volume:
159,220
Relative Volume:
0.68
Market Cap:
$44.65M
Revenue:
$34.90M
Net Income/Loss:
-$15.38M
P/E Ratio:
-
EPS:
-$1.81
Net Cash Flow:
-$6.87M
1W Performance:
-37.31%
1M Performance:
-38.34%
6M Performance:
-22.81%
1Y Performance:
-7.98%
1-Day Range:
$4.69$5.75
1-Week Range:
$4.37$8.32
52-Week Range:
$4.37$12.70
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore IncSector
HealthcareIndustry
Medical DevicesPhone
973-290-0097Address
200 FORGE WAY, ROCKAWAY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS